Cargando…

Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?

BACKGROUND: There is an urgent need to identify effective therapy to treat coronavirus diseases 2019 (COVID-19). Supplement consumption is becoming popular in this pandemic era. An example of this is probiotic consumption to improve the host's immune system. OBJECTIVE: This study aimed to prove...

Descripción completa

Detalles Bibliográficos
Autores principales: Veterini, Anna Surgean, Prakoeswa, Cita Rosita Sigit, Tinduh, Damayanti, Satuman, Satuman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468316/
https://www.ncbi.nlm.nih.gov/pubmed/36120494
http://dx.doi.org/10.1016/j.bbrep.2022.101348
_version_ 1784788382299193344
author Veterini, Anna Surgean
Prakoeswa, Cita Rosita Sigit
Tinduh, Damayanti
Satuman, Satuman
author_facet Veterini, Anna Surgean
Prakoeswa, Cita Rosita Sigit
Tinduh, Damayanti
Satuman, Satuman
author_sort Veterini, Anna Surgean
collection PubMed
description BACKGROUND: There is an urgent need to identify effective therapy to treat coronavirus diseases 2019 (COVID-19). Supplement consumption is becoming popular in this pandemic era. An example of this is probiotic consumption to improve the host's immune system. OBJECTIVE: This study aimed to prove whether antibodies from people taking probiotics could influence lactate dehydrogenase (LDH), adenosine triphosphate (ATP) values, and cell viability in vitro in peripheral blood mononuclear cells (PBMCs) inoculated with the SARS-CoV-2 spike protein as COVID-19 cells models. METHODS: This was an experimental study with control and intervention groups, totally in 12 groups divided based on antibody levels, probiotic intervention, probiotic non-intervention group, SARS-CoV-2 infection group, and non-SARS-CoV-2 infection group. In vitro assays were carried out on PBMC cell cultures inoculated with S1 SARS-CoV-2 recombinant as a COVID-19 cell model. The COVID-19 cell model was given antibodies divided into three antibody level groups: sRBD levels of <3, 325.76 and 646.18. The cytotoxicity assessment examined increased levels of LDH, cytopathic activity by measuring ATP levels, and cell viability by XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) assay. Data were analyzed with SPSS 21 for Windows. RESULTS: This study showed a significant difference in the LDH value (p < 0.001) between each group. The difference in ATP values between groups was significant (p < 0.001). Meanwhile, the cell viability examination found that there was a tendency of decreased XTT (cell viability in %) when there was an increase of LDH and ATP. CONCLUSION: The change of LDH values occurred most in the antibody group that did not consume probiotics. The highest cytopathic activity based on the ATP values occurred in the infected cell culture group with antibody levels of 325.76 and consuming probiotics. In addition, LDH and ATP activities provided evidence of a significant influence on cell viability.
format Online
Article
Text
id pubmed-9468316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94683162022-09-13 Simple neutralization test report: Do probiotics contribute to COVID-19 therapy? Veterini, Anna Surgean Prakoeswa, Cita Rosita Sigit Tinduh, Damayanti Satuman, Satuman Biochem Biophys Rep Research Article BACKGROUND: There is an urgent need to identify effective therapy to treat coronavirus diseases 2019 (COVID-19). Supplement consumption is becoming popular in this pandemic era. An example of this is probiotic consumption to improve the host's immune system. OBJECTIVE: This study aimed to prove whether antibodies from people taking probiotics could influence lactate dehydrogenase (LDH), adenosine triphosphate (ATP) values, and cell viability in vitro in peripheral blood mononuclear cells (PBMCs) inoculated with the SARS-CoV-2 spike protein as COVID-19 cells models. METHODS: This was an experimental study with control and intervention groups, totally in 12 groups divided based on antibody levels, probiotic intervention, probiotic non-intervention group, SARS-CoV-2 infection group, and non-SARS-CoV-2 infection group. In vitro assays were carried out on PBMC cell cultures inoculated with S1 SARS-CoV-2 recombinant as a COVID-19 cell model. The COVID-19 cell model was given antibodies divided into three antibody level groups: sRBD levels of <3, 325.76 and 646.18. The cytotoxicity assessment examined increased levels of LDH, cytopathic activity by measuring ATP levels, and cell viability by XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) assay. Data were analyzed with SPSS 21 for Windows. RESULTS: This study showed a significant difference in the LDH value (p < 0.001) between each group. The difference in ATP values between groups was significant (p < 0.001). Meanwhile, the cell viability examination found that there was a tendency of decreased XTT (cell viability in %) when there was an increase of LDH and ATP. CONCLUSION: The change of LDH values occurred most in the antibody group that did not consume probiotics. The highest cytopathic activity based on the ATP values occurred in the infected cell culture group with antibody levels of 325.76 and consuming probiotics. In addition, LDH and ATP activities provided evidence of a significant influence on cell viability. Elsevier 2022-09-13 /pmc/articles/PMC9468316/ /pubmed/36120494 http://dx.doi.org/10.1016/j.bbrep.2022.101348 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Veterini, Anna Surgean
Prakoeswa, Cita Rosita Sigit
Tinduh, Damayanti
Satuman, Satuman
Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_full Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_fullStr Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_full_unstemmed Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_short Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_sort simple neutralization test report: do probiotics contribute to covid-19 therapy?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468316/
https://www.ncbi.nlm.nih.gov/pubmed/36120494
http://dx.doi.org/10.1016/j.bbrep.2022.101348
work_keys_str_mv AT veteriniannasurgean simpleneutralizationtestreportdoprobioticscontributetocovid19therapy
AT prakoeswacitarositasigit simpleneutralizationtestreportdoprobioticscontributetocovid19therapy
AT tinduhdamayanti simpleneutralizationtestreportdoprobioticscontributetocovid19therapy
AT satumansatuman simpleneutralizationtestreportdoprobioticscontributetocovid19therapy